Calithera Biosciences

Calithera Biosciences is a clinical-stage precision oncology biopharmaceutical company developing targeted therapies to redefine treatment for patient populations with specific biomarkers. Calithera is advancing a robust pipeline of investigational small-molecule oncology compounds using a biomarker-driven approach, targeting genetically vulnerable cancer cells to provide new treatment options for patients with aggressive hematologic malignancies and solid tumors, where current treatment options are limited.